Sonodynamic therapy (SDT), as a noninvasive treatment with preferable therapeutic depth,
has attracted widespread attention. However, current sonosensitizers suffer from a low …

Sonodynamic therapy (SDT) typically suffers from compromised anticancer efficacy owing to
the low reactive oxygen species (ROS) yield and complicated tumor microenvironment …

Novel sonosensitizers with intrinsic characteristics for tumor diagnosis, efficient therapy, and
tumor microenvironment regulation are appealing in current sonodynamic therapy. Herein, a …

The high reactive oxygen species (ROS) generation ability and simple construction of
sonosensitizer systems remain challenging in sonodynamic therapy against the hypoxic …

Reactive oxygen species (ROS) has been employed as a powerful therapeutic agent for
eradicating tumor via oxidative stress. As an emerging ROS‐involving noninvasive …

Sonodynamic therapy (SDT), which uses reactive oxygen species to target tumors, has
shown promise in the management of unresectable cancers. However, the hypoxic tumor …

Sonodynamic therapy (SDT) triggered by ultrasound (US) has attracted increasing attention
owing to its abilities to overcome critical limitations including low tissue‐penetration depth …

As an effective tumor-therapeutic modality, ultrasound-triggered sonodynamic therapy (SDT)
has been extensively explored to induce cancer cell death by activating sonosensitizers to …

Ultrasound (US)-triggered sonodynamic therapy (SDT) has aroused intensive interest as a
powerful alternative for cancer treatment in recent years due to its non-invasiveness and …

The hypoxic tumor microenvironment (TME) and non-specific distribution of sonosensitizers
are two major obstacles that limit practical applications of sonodynamic therapy (SDT) in …